99mTC-MIBI scintingraphy compared to the mammography in the diagnosis of breast cancer in dense, operated and young women's breasts;Gammagrafía con 99mTc-MIBI frente a la mamografía en el diagnóstico de cáncer de mama en mamas densas, mamas intervenidas y mujeres jóvenes

Revista Espanola de Medicina Nuclear

Volumn 19, Issue 5, 2000, Pages 344-349

  Mulero Aniorte, Francisca ^a,b   Nicolas F ^a   Castellon M I ^a   Fuentes, T ^a   De La Cruz, P ^a   Roca, V ^a   Abad, L ^a   Nuno De La Rosa J A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b NONE   (Spain)

Author keywords

Breast cancer; Mammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCINTISCANNING; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; AGE; BREAST; BREAST TUMOR; COMPARATIVE STUDY; PAGET NIPPLE DISEASE; PATHOLOGY; SCINTISCANNING; TUMOR RECURRENCE;

ADULT; AGE FACTORS; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MAMMOGRAPHY; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 17744420855     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/s0212-6982(00)71888-x     Document Type: Article

References (28)

1. Adler DD, Whal RL. New methods for imaging the breast: techniques, findings and potential. AJR 1995;164:19-30.
2. AECC Asociación Española Contra el Cáncer 1997. Memoria de trabajo. Murcia 1996.
3. Dupont W, Page D. Risk factors for breast cancer in women with proliferative breast disease. New Engl J Med 1985;312:146-51.
4. Ciatto S, Ambrogetti D, Muraca M. Combined diagnosis of breast cancer recurrences after conservative treatment. Critical review of 143 consecutive cases. Radiol Med Torino 1995;90:383-5.
5. Rosen P, Fracchia A, Urban J. «Residual» mammary carcinoma following simulated partial mastectomy. Cancer 1975;35:739.
6. Chu F, Lin F, Kim J, Lu G, Shih W, Huang H, et al. Locally recurrent carcinoma of the breast. Cancer 1976;37:2677.
7. Kopans D. Imaging analysis of breast lesions. En: Diseases of the breast, edited by Harris J, Lippman M, Morrow M. Lippincott-Raven Publishers, Philadelphia; 1996. p. 71-83.
8. 99mTc Methoxyisobutitylisonitrile in imaging breast cancer. Sem Nucl Med 1997;2740-54.
9. Tabar L, Fagerber G, duffy SW, Day EN. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 1989;43:107-14.
10. Kopans DB. Positive predictive value of mammography. AJR 1992;158:521-6.
11. Bombardieri E, Crippa F, Maffioli G, et al. Nuclear Medicine techniques for the study of breast cancer. Eur J Nucl Med 1997;24:809-24.
12. Ennis J. Diagnóstico radiológico por imágenes de las enfermedades mamarias. En: La mama. Manejo multidisciplinario de las enfermedades benignas y malignas. Eduard M-Copeland III. Ed Panamericana; 1995. p. 542-82.
13. Jackson VP, Hendrich RE, Kerg SA, et al. Imaging of the radiographically dense breast. Radiology 1993;188:297-301.
14. Di Maggio C, Andreoli C, Costa A, et al. Neoplasias mamarias: Métodos de diagnóstico. En: Caleidoscopio revista monográfica de Medicina. Madrid: Ed Medical Systems 1991. p. 10-35.
15. 99mTc-MIBI en el diagnóstico de las recurrencias del cáncer de mama postratamiento conservador. Rev Esp Med Nuclear 1997;16(4):250-4.
16. Rosen P, Fracchia A, Urban J, et al. «Residual» mammary carcinoma following simulated partial mastectomy. Cancer 1975;35:739.
17. Vincini F, Recht A, Abner A, et al. recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. Monogr Natl Canc Inst 1992;11:33-9.
18. Niloff PH, Sheiner NM. False-negative mammograms in patients with breast cancer. Can J Surg 1981;24:50-2.
19. Mund D, Farria D, Gorczyca D, DeBruhl N, Ahn C, Shaw W, Bassett L. MR imaging of the breast in patients with silicone-gel implants: spectrum of findings. AJR 1993;161(4);773-8.
20. 99mTc- MIBI». Presentación de resultados Rev Esp Med Nucl 1998;17(5):338-50.
21. Palmedo H, Shomburg A, Grünwald F, Mallmann P, Krebs D, Biersack H, et al. Scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;37:626-30.
22. 99mTc-MIBI en Oncología. Rev Esp Med Nucl 1994;13:4-14.
23. Khalkhali I, Cutrone J, Mena I, Diggles L, Stuntz M, Mishkin F, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995;36:1784-9.
24. Khalkhali I, Villanueva-Meyer J, Edell S, Hanelin L, Liugo C, Taillefer R. Diagnostic accuracy of Tc-99 sestamibi breast imaging in breast cancer detection (abstract). J Nucl Med 1996;37:74.
25. Khalkhali I, Cutrone J, Diggles L, Iraniha S, Klein S. The role of Nuclear Medicine Imaging for the Evaluation of patients with Breast abnormalities. En: Nuclear Medicine Annual 1996. Editado por Freeman L. Lippincott-Raven Publishers, Philadelphia 1996. p. 113-41.
26. 99mTc- sestamibi is a transport substrate recognized by the multidrug-resistence P-glycoprotein. Cancer Res 1993;53:977-84.
27. Hendrikse N, Franssen E, van der Graaf W, Vaalburg W, de Vries E. Visualization of multidrug resistance in vivo. Br J Cancer 1998;77:353-8.
28. Kostakoglu L, Ruacan S, Ergun E, Sayec I, Elahi N, Bekdik C. Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIBI uptake inbreast cancer. J Nucl Med 1997;38:1003-8.